相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neutrophil plasticity in the tumor microenvironment
Morgan A. Giese et al.
BLOOD (2019)
G-CSF administration prior to donor lymphocyte apheresis promotes anti-leukaemic effects in allogeneic HCT patients
Corina Schneidawind et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
Ke Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells
Jilu Zhang et al.
LEUKEMIA (2019)
Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation
Lisha Ai et al.
MOLECULAR CANCER (2019)
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
Jerome Mastio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities
Sabina Sangaletti et al.
FRONTIERS IN IMMUNOLOGY (2019)
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
Livingstone Fultang et al.
EBIOMEDICINE (2019)
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Hanna Grauers Wiktorin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Targetting the Tumor Microenvironment of Leukemia and Lymphoma
Uta E. Hoepken et al.
TRENDS IN CANCER (2019)
Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases
Ji-Young Lim et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
Bruce R. Blazar et al.
BLOOD (2018)
Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly
A. Betsch et al.
BLOOD REVIEWS (2018)
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
Alessandra Romano et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
Liru Wang et al.
ONCOIMMUNOLOGY (2018)
Targeting the IDO1 pathway in cancer: from bench to bedside
Ming Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
Peng-Fei Wang et al.
ONCOIMMUNOLOGY (2018)
High myeloid-derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T-cell lymphoma and its precursor lesions
Hetty J. Bontkes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia
Qian Fan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
Brent H. Koehn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Expansion and activation of granulocytic, myeloid-derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia
Yu-feng Liu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858
E. A. Eksioglu et al.
LEUKEMIA (2017)
Mechanisms of Immune Tolerance in Leukemia and Lymphoma
Emily K. Curran et al.
TRENDS IN IMMUNOLOGY (2017)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Sara Trabanelli et al.
NATURE COMMUNICATIONS (2017)
Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
Juan R. Cubillos-Ruiz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
Athalia Rachel Pyzer et al.
BLOOD (2017)
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Imane Azzaoui et al.
BLOOD (2016)
Myeloid-derived suppressor cells: The green light for myeloma immune escape
Ehsan Malek et al.
BLOOD REVIEWS (2016)
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy
Indu R. Ramachandran et al.
CANCER LETTERS (2016)
G-CSF Induced Suppressor IL-10+ Neutrophils Promote Regulatory T Cells That Inhibit Graft-Versus-Host Disease in a Long-Lasting and Specific Way
Suelen Martins Perobelli et al.
JOURNAL OF IMMUNOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
Cesarina Giallongo et al.
ONCOTARGET (2016)
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients
Olivia Marini et al.
ONCOTARGET (2016)
The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
Chunwan Lu et al.
ONCOIMMUNOLOGY (2016)
In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity
Joanna J. Messmann et al.
BLOOD (2015)
Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator
Han Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
B. Xiu et al.
BLOOD CANCER JOURNAL (2015)
Clinical impact of the immunome in lymphoid malignancies: the role of myeloid-derived suppressor cells
Calogero Vetro et al.
FRONTIERS IN ONCOLOGY (2015)
Myeloid derived suppressor cells in chronic myeloid leukemia
Cesarina Giallongo et al.
FRONTIERS IN ONCOLOGY (2015)
Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation
Meng Lv et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
Alessandra Romano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Tumor-induced CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients
Zhitao Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Graft Monocytic Myeloid-Derived Suppressor Cell Content Predicts the Risk of Acute Graft-versus-Host Disease after Allogeneic Transplantation of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Stem Cells
Antonio Vendramin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
Regina Jitschin et al.
BLOOD (2014)
Mechanisms of action of tasquinimod on the tumour microenvironment
E. Raymond et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
A. M. Molina et al.
EUROPEAN JOURNAL OF CANCER (2014)
CD14+ HLA-DR low/-monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma
K. A. Khalifa et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
James Favaloro et al.
LEUKEMIA & LYMPHOMA (2014)
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
Hong Qin et al.
NATURE MEDICINE (2014)
Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+T Cell-Mediated Antitumor Effects
Tae Heung Kang et al.
PLOS ONE (2014)
Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients
Cesarina Giallongo et al.
PLOS ONE (2014)
Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
Kimberly A. Noonan et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice
Dapeng Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Guellue Topal Goerguen et al.
BLOOD (2013)
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events
Elio Schouppe et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphomapossible link with monocytic myeloid-derived suppressor cells
Tamar Tadmor et al.
HEMATOLOGICAL ONCOLOGY (2013)
Induction of myelodysplasia by myeloid-derived suppressor cells
Xianghong Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
Indu R. Ramachandran et al.
JOURNAL OF IMMUNOLOGY (2013)
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
D. Mougiakakos et al.
LEUKEMIA (2013)
Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Lisa Christiansson et al.
PLOS ONE (2013)
Immune Regulatory Activity of Vitamin D3 in Head and Neck Cancer
M. Young et al.
Cancers (2013)
Cucurbitacin B Regulates Immature Myeloid Cell Differentiation and Enhances Antitumor Immunity in Patients with Lung Cancer
Ping Lu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Aparna Rao et al.
CANCER RESEARCH (2012)
G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells
Ariane Luyckx et al.
CLINICAL IMMUNOLOGY (2012)
Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice
Chi Ma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
E. Van Valckenborgh et al.
LEUKEMIA (2012)
S100A9 Interaction with TLR4 Promotes Tumor Growth
Eva Kallberg et al.
PLOS ONE (2012)
Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
Junling Zhuang et al.
PLOS ONE (2012)
Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
Yi Lin et al.
BLOOD (2011)
Myeloid-derived suppressor cells - their role in haemato-oncological malignancies and other cancers and possible implications for therapy
Tamar Tadmor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model
Mengde Cao et al.
LABORATORY INVESTIGATION (2011)
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Joris D. Veltman et al.
BMC CANCER (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
M. K. Brimnes et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox et al.
BLOOD (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
Olga Turovskaya et al.
CARCINOGENESIS (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunodeficiency and immunotherapy in multiple myeloma
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang et al.
CANCER RESEARCH (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance
S Rutella et al.
JOURNAL OF IMMUNOLOGY (2005)
Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells
KPA MacDonald et al.
JOURNAL OF IMMUNOLOGY (2005)
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals
LH Zou et al.
CANCER RESEARCH (2004)
L-arginine consumption by macrophages modulates the expression of CD3ξ chain in T lymphocytes
PC Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2003)
G-CSF as immune regulator in T cells expressing the G-CSF receptor:: implications for transplantation and autoimmune diseases
A Franzke et al.
BLOOD (2003)
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro
MP Manitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Vitamin A deficiency in mice causes a systemic expansion of myeloid cells
T Kuwata et al.
BLOOD (2000)
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
M Arpinati et al.
BLOOD (2000)
分享论文
